| Health / Medical Topics |
PR-151 Peptide
A tumor-specific peptide encoded by patient-specific mutant p53 oncogene with potential immunostimulatory properties. The peptide (LPTGQDL) contains a frame shift mutation at amino acid position 134. It was used to pulse dendritic cells, which are then used in the adoptive immunotherapy setting and may stimulate the host immune system to mount a specific cytotoxic T lymphocyte response against tumor cells expressing the p35 mutation. (NCI Thesaurus)
YOU MAY ALSO LIKE
A substance being studied in the treatment of cancer. PR-104 becomes active when cancer cells don’t receive enough oxygen. It may kill…
Describes cells that do not have a protein to which the hormone progesterone will bind. Cancer cells that are PR- do not…
A question associated with the PR version 1 questionnaire.
The time interval between the start of the P wave and the beginning of the QRS complex in the cardiac cycle. …
PR domain zinc finger protein 4 (801 aa, ~88 kDa) is encoded by the human PRDM4 gene. This protein plays a role…
PR domain zinc finger protein 16 (1276 aa, ~140 kDa) is encoded by the human PRDM16 gene. This protein plays a role…
